Cowen Starts Ocular Therapeutix (OCUL) at Outperform
Tweet
Share
E-mailGet Alerts OCUL Hot Sheet
Price: $9.10 +1.45%
Rating Summary:
20 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 42
Rating Summary:
20 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 42
Join SI Premium – FREE
Cowen initiated coverage on Ocular Therapeutix (NASDAQ: OCUL) with an Outperform rating and a price target of $40.00.
For an analyst ratings summary and ratings history on Ocular Therapeutix click here. For more ratings news on Ocular Therapeutix click here.
Shares of Ocular Therapeutix closed at $14.33 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
- BofA Securities Reinstates Bunzl Plc. (BNZL:LN) (BZLFY) at Underperform
- Ocular Therapeutix (OCUL) Reiterated at Market Outperform by Citizens Ahead of Q2 Earnings
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
